TABLE 1.
Disease | Effect | Responses | References |
---|---|---|---|
Hypertension | Increased | ↑MPS cells | 46 |
↑DCs | 110 | ||
↑Th17 cells and IL‐17 | 130 | ||
↓Lactobacillus spp. | 130 | ||
Actively induced EAE | Exacerbated | ↑Th17 cells | 130 |
↓Lactobacillus spp. | 130 | ||
↑Pro‐inflammatory myeloid cells | 45 | ||
↑Blood–brain barrier permeability | 141 | ||
Spontaneous EAE | Suppressed | ↓Blood–brain barrier permeability | 142 |
Experimental colitis | Exacerbated | ↑Macrophages | 143, 144, 145 |
↑Th17 cells and ILC3 | 131, 146, 147 | ||
↓Treg cells | 132 | ||
↓Lactobacillus spp. and butyrate | 131 | ||
↑Intestinal fibroblasts | 148 | ||
Systemic lupus erythematosus | Exacerbated | ↑Th1 and Th17 cells | 149 |
↑Tfh cells | 62 | ||
↑DCs | 112 | ||
Collagen‐induced arthritis | Exacerbated | ↑Th17 cells and IL‐17 | 150 |
No significant influence | / | 151 | |
K/BxN serum transfer‐induced arthritis | No significant influence | / | 151 |
Cancer | Exacerbated | ↑Th17 cells and IL‐17 | 152 |
↑Helicobacter pylori infection | 153 | ||
Inhibited | ↓MDSCs | 154, 155 | |
↑T cells | 154 | ||
↑Bifidobacterium and NK cross‐talk | 86 | ||
Infection | Exacerbated | ↓Neutrophils | 82 |
Prevented | ↑M1 and ↓M2 macrophages | 41, 97, 156, 157 | |
Ischemic stroke | Aggravated | ↑Blood–brain barrier disruption | 158 |
↑M1 and ↓M2 macrophages | 159, 160 | ||
Cognitive disorders | Impaired | ↑Th17 cells and IL‐17 | 161 |
↑M1 microglia | 162 | ||
Wound healing | Delayed | ↓M2 macrophages | 56 |
Acute renal failure | Aggravated | ↑Th17 cells | 163, 164 |
Transplantation rejection | Accelerated | ↓Treg cells | 55, 132 |
Osteopenia | Increased | ↑Th17 cells and ↓Treg cells | 165 |
↑: increased; ↓: decreased.